The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia.

Clinical trials were halted after the treatment’s vector that ferries in the healthy genetic sequence was identified in the genome of a patient’s cancer cells.

Phages interact with bacteria and eukaryotic cells in ways that researchers suspect influence mammalian health.

In both Drosophila and mosquitoes, protection lasts for generations following a single maternal exposure to positive-sense single-stranded RNA viruses.

Adeno-associated viral vectors can deliver gene therapies, but AAV-neutralizing antibodies might prevent the medicines from working.

Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?

Canines treated with an adeno-associated viral (AAV) vector showed evidence that the therapeutic DNA held within the virus can integrate into the host genome, risking the activation of oncogenes.

Researchers are devising ways to prevent viral vectors carrying gene therapies from triggering an immune response.

Tiny insects carry the tomato spotted wilt virus, which causes infected plants to develop discolored ring-shape blotches.

Researchers boosted levels of the dystrophin protein to nearly normal levels in a canine model of the disease.

Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.

Biotech stocks fell in response to the news. 

The gene-editing tool was effective in disabling a defective gene responsible for some forms of amyotrophic lateral sclerosis.